直视下尿道内切开术治疗短段前尿道狭窄及其扩展应用:成功率、治疗失败预测因素与复发管理
本研究纳入2009年12月至2016年3月间接受前尿道直视下尿道内切开术(DVIU)的128例患者,通过电话随访评估成功率。中位随访16个月时总成功率为51.6%(N=66),中位复发时间为6个月。仅重复DVIU是复发的风险因素(多变量HR=1.78,95%CI=1.05-3.03,P=.032)。复发患者中35.5%接受尿道成形术,29%接受进一步内镜治疗,33.9%未接受进一步介入治疗。
要点
- 中位随访16个月时DVIU总成功率为51.6%(N=66),中位复发时间6个月。
- 重复DVIU是狭窄复发的独立风险因素(多变量HR=1.78,95%CI=1.05-3.03,P=.032)。
- 复发患者中33.9%未接受进一步介入治疗,高龄和糖尿病是其预测因素。
核心结论
- DVIU似乎可作为短段尿道狭窄的初次治疗选择。
- 既往DVIU是复发的风险因素。
- 复发时约三分之一患者未接受任何进一步治疗,高龄和糖尿病预测拒绝进一步治疗。
研究设计与样本
- 回顾性识别2009年12月至2016年3月间接受前尿道DVIU的128例患者,通过电话访谈随访。
- 采用Kaplan-Meier法评估成功率,采用单变量和多变量Cox回归分析识别狭窄复发预测因素及不同后续治疗策略。
主要发现
- 平均年龄63.8岁(标准差16.3),中位随访16个月(四分位距6-43)时总成功率为51.6%(N=66)。
- 中位狭窄复发时间为6个月(四分位距2-12)。
- 单变量分析中重复DVIU是复发的风险因素(HR=1.87,95%CI=1.13-3.11,P=.015),多变量分析中亦为风险因素(HR=1.78,95%CI=1.05-3.03,P=.032)。
- 62例复发患者中,35.5%接受尿道成形术,29%接受进一步内镜治疗,33.9%未接受进一步介入治疗。
- 年龄(HR=1.05,95%CI=1.01-1.09,P=.019)和糖尿病(HR=2.90,95%CI=1.02-8.26,P=.047)是未接受进一步介入治疗的预测因素。
临床怎么用
- 作者认为DVIU似乎可作为短段尿道狭窄的初次治疗。
- 作者指出既往DVIU是复发的风险因素。
- 作者报告复发时约三分之一患者未接受任何进一步治疗,高龄和糖尿病预测拒绝进一步治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine success rates, predictors of recurrence, and recurrence management of patients treated for short anterior urethral strictures by direct vision internal urethrotomy (DVIU). MATERIALS AND METHODS: We identified 128 patients who underwent DVIU of the anterior urethra between December 2009 and March 2016. Follow-up was conducted by telephone interviews. Success rates were assessed by Kaplan-Meier estimators. Predictors of stricture recurrence and different further therapy strategies were identified by uni- and multivariable Cox regression analyses. RESULTS: The mean age was 63.8 years (standard deviation: 16.3) and the overall success rate was 51.6% (N = 66) at a median follow-up of 16 months (interquartile range: 6-43). Median time to stricture recurrence was six months (interquartile range: 2-12). In uni- and multivariable analyses, only repeat DVIU (hazard ratio [HR] = 1.87, 95% confidence interval (CI) = 1.13-3.11, P= .015; and HR=1.78, 95% CI = 1.05-3.03, P = .032, respectively) was a risk factor for recurrence. Of 62 patients with recurrence, 35.5% underwent urethroplasty, 29% underwent further endoscopic treatment, and 33.9% did not undergo further interventional therapy. Age (HR = 1.05, 95% CI = 1.01-1.09, P = .019) and diabetes (HR = 2.90, 95% CI = 1.02-8.26, P = .047) were predictors of no further interventional therapy. CONCLUSION: DVIU seems justifiable in short urethral strictures as a primary treatment. Prior DVIU was a risk factor for recurrence. In case of recurrence, about one-third of the patients did not undergo any further therapy. Higher age and diabetes predicted the denial of any further treatment.
引用
- Kluth LA, Ernst L, Vetterlein MW, et al. Direct Vision Internal Urethrotomy for Short Anterior Urethral Strictures and Beyond: Success Rates, Predictors of Treatment Failure, and Recurrence Management. Urology. 2017. PMID: 28479479. doi:10.1016/j.urology.2017.04.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。